Publications by authors named "Weiming Han"

Claim this Profile
L
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trial.
Junqiang Chen, Xiao Chang, Wenyang Liu, Xiaomin Wang, Xiaolin Ge, Jihong Zhang, Weiming Han, Tao Zhang, Kaixian Zhang, Chun Han, Wencheng Zhang

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial.
Weiming Han, Linrui Gao, Xiaomin Wang, Chen Li, Zongmei Zhou, Tao Zhang

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma.
Fangdong Zhao, Qifeng Wang, Weiming Han, Wubulaishan Maitudi, Fuliang Cao, Tian Zhang, Xiaobin Shang, Wencheng Zhang

Cancer Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiota in colorectal cancer related to liver metastasis.
Peijun Wei, Weiming Han, Zitong Zhang, Xue Tian, Chen Yang, Hui Chang

Chin J Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Xin Wang, Weiming Han, Wencheng Zhang, Xiaomin Wang, Xiaolin Ge, Jihong Zhang, Chun Han, Kaixian Zhang, Tao Zhang

JAMA Netw Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma.
Weiming Han, Wei Deng, Qifeng Wang, Wenjie Ni, Chen Li, Tao Zhang

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma.
Weiming Han, Xiao Chang, Wencheng Zhang, Jingsong Yang, Shufei Yu

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting the completion of concurrent chemotherapy and impact of non-completion on survival in locally advanced esophageal squamous cell carcinoma.
Shijia Wang, Baoyan Ji, Chen Li, Weiming Han, Xin Wang, Tao Zhang

Esophagus· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Dose-Effect Relation in Patients with Esophageal Squamous Cell Carcinoma: A National Cancer Center Data and Literature-Based Analysis.
Weiming Han, Chen Li, Wei Deng, Wenjie Ni, Xiao Chang

J Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.
Weiming Han, Lan Wang, Chen Li, Junqiang Chen, Wencheng Zhang, Kaixian Zhang, Tao Zhang, Xiao Chang, Chun Han

Ther Adv Med Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy.
Lin-Rui Gao, Chen Li, Weiming Han, Wenjie Ni, Wei Deng, Tao Zhang

Ther Adv Med Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis.
Xiao Chang, Wei Deng, Wenjie Ni, Chen Li, Weiming Han

Ann Surg Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.
Chen Li, Lijun Tan, Xiao Liu, Xin Wang, Zongmei Zhou, Tao Zhang, Xiao Chang, Weiming Han

Thorac Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.
Chen Li, Lijun Tan, Xiao Liu, Xin Wang, Zongmei Zhou, Tao Zhang, Xiao Chang, Weiming Han

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey.
Chen Li, Xin Wang, Lan Wang, Junqiang Chen, Wencheng Zhang, Kaixian Zhang, Tao Zhang, Xiao Chang, Weiming Han, Chun Han

Acta Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol.
Xiao Chang, Lei Deng, Wenjie Ni, Chen Li, Weiming Han

BMC Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
Lin-Rui Gao, Xin Wang, Weiming Han, Wei Deng, Chen Li, Xiao Chang, Tao Zhang

BMC Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03).
Wencheng Zhang, Jingjing Zhao, Weiming Han, Hualei Zhang, Xin Wang, Chun Han, Kaixian Zhang

Ann Transl Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial.
Xin Wang, Xiaolin Ge, Xiaomin Wang, Wencheng Zhang, Haiwen Zhou, Kaixian Zhang, Xiao Chang, Weiming Han, Tao Zhang

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled Study.
Wei Deng, Jinsong Yang, Wenjie Ni, Chen Li, Xiao Chang, Weiming Han, Tao Zhang, Zhishan Li, Lei Han

Oncologist· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis